欧洲 · 通讯社与实时数据 · Reuters US Markets
India's Cipla misses second-quarter profit view on muted US sales
Cipla , India's third-largest drugmaker by revenue, missed second-quarter profit estimates on Tuesday, as muted sales of generic Revlimid and stiff competition weighed on…
在 Reuters US Markets 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.reuters.com)
